Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
HALO compared with GMED: revenue, margins and what each company keeps, and the suppliers and customers both name
HALO
Halozyme Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
GMED
Globus Medical Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
HALO
Halozyme Therapeutics, Inc.
vs
GMED
Globus Medical Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
HALO, solid
GMED, dashed
HALO
Halozyme Therapeutics, Inc.
Change
103.73
▼
−15.64%
· post 104.00
Mkt cap
$11.8B
Revenue
$493M
Q3 FY26
Revenue
$1.4B
FY25
GMED
Globus Medical Inc
Change
70.94
▼
−12.89%
· post 71.30
Closed
Nov 6 '26
Mkt cap
$9.4B
Revenue
$764M
Q3 FY26
Revenue
$2.9B
FY25
vs
Compare
Closed
Nov 6 '26
HALO
Halozyme Therapeutics, Inc.
vs
GMED
Globus Medical Inc
103.73
▼
−15.64%
post 104.00
Price
70.94
▼
−12.89%
post 71.30
$11.8B
Mkt cap
$9.4B
Q3 FY26
$493M
Revenue
$764M
Q3 FY26
FY25
$1.4B
Revenue
$2.9B
FY25
Change
Change
HALO
103.73
▼
−15.64%
vs
GMED
70.94
▼
−12.89%
Closed
Nov 6 '26